secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0000927653-22-000074
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson Q1 adj EPS $5.83, revenue $67.2B; raises FY2023 outlook to $23.95-$24.65
--------------------------------------------------------------------------------

- Adjusted EPS $5.83 vs $5.56 (+5%); GAAP EPS $5.25 vs $3.09 (+70%).
- Revenue $67.2B, up 7% YoY, driven by U.S. pharmaceutical and specialty distribution.
- FY2023 adjusted EPS guidance raised to $23.95-$24.65 from $22.90-$23.60.
- Core adjusted EPS growth (ex-COVID programs) forecasted at 10-15% for fiscal 2023.
- Guidance includes COVID vaccine distribution contribution of $0.35-$0.45 and ancillary supplies/testing of $0.75-$0.95 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/0000927653-22-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/mck-20220803.htm
  HTML page:      https://secwatch.observer/filing/0000927653-22-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer